Recombinant Anti-FCER2 Antibody (V3S-0622-YC176) (CAT#: V3S-0622-YC176)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a chimeric antibody against human CD23. The antibody can be applied to the CD23 expression detection in a scientific research and immunohistochemistry assay.
Clonality Monoclonal
Host Species Human
Target Species Human
Immunogen Recombinant human CD23 expressed in E. coli.
Isotype IgG1

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; IHC
Application Notes The antibody is recommended for detection of FCER2 by ELISA, IHC (1/20-1/200) assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target FCER2
Alternative Name CD23; FCE2; CD23A; IGEBF; CLEC4J; BLAST-2; low affinity immunoglobulin epsilon Fc receptor; C-type lectin domain family 4, member J; CD23 antigen; Fc epsilon receptor II; Fc fragment of IgE, low affinity II, receptor for (CD23); fc-epsilon-RII; immunoglobulin E-binding factor; immunoglobulin epsilon-chain; lymphocyte IgE receptor
Gene ID 2208
UniProt P06734
Research Area Cell Biology; Immunology
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry